Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium
- 14 November 2009
- journal article
- hepatobiliary pancreas
- Published by Springer Nature in European Radiology
- Vol. 20 (5) , 1052-1060
Abstract
Objective To determine whether intravenous administration of gadoxetic acid disodium (Gd-EOB-DTPA) affects lesion conspicuity and apparent diffusion coefficient (ADCs) in diffusion-weighted imaging (DWI) for hepatic magnetic resonance imaging (MRI) at 3.0 T. Methods Thirty-four patients with 50 focal hepatic lesions (18 hepatocellular carcinomas, 12 metastases, 1 cholangiocarcinoma, 7 haemangiomas, 12 cysts) underwent DWI at 3.0 T before and after administration of Gd-EOB-DTPA. Non-breath-hold DWI was performed with b values of 0, 200, 400 and 800 s/mm2. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of each lesion, and ADCs of the liver and lesion were calculated for unenhanced and enhanced images. Statistical differences between unenhanced and enhanced data were assessed. Results SNRs and ADCs of the liver on enhanced images were significantly lower than on unenhanced images. On DW images at b = 200 s/mm2, CNRs of malignant and overall lesions were significantly higher on enhanced than on unenhanced images. CNRs of focal lesions tended to be higher, especially in malignant lesions, on DW images at b = 0 and 400 s/mm2, but without reaching statistical significance. ADCs of focal hepatic lesions were not significantly different before and after administration of contrast agent. Conclusion DWI after Gd-EOB-DTPA administration can be used as a substitute for unenhanced DWI at 3.0 T without compromising CNR and ADC of focal hepatic lesions.Keywords
This publication has 22 references indexed in Scilit:
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- MR Imaging in Patients with Suspected Liver Metastases: Value of Liver-specific Contrast Agent Gd-EOB-DTPAMagnetic Resonance in Medical Sciences, 2007
- Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field StrengthsInvestigative Radiology, 2005
- Effect of Intravenous Gadolinium-DTPA on Diffusion-Weighted Magnetic Resonance Images for Evaluation of Focal Hepatic LesionsJournal of Computer Assisted Tomography, 2005
- Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsEuropean Radiology, 2004
- Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic CorrelationRadioGraphics, 2002
- Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imagingJournal of Magnetic Resonance Imaging, 2002
- Breath-Hold T2-Weighted MRI of Hepatic Tumors: Value of Echo Planar Imaging with Diffusion-Sensitizing GradientJournal of Computer Assisted Tomography, 1998
- Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluationEuropean Radiology, 1997
- Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.Radiology, 1995